FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DAVIS JAMES L
2. Issuer Name and Ticker or Trading Symbol

ProUroCare Medical Inc. [ PUMD ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

6446 FLYING CLOUD DR
3. Date of Earliest Transaction (MM/DD/YYYY)

8/9/2012
(Street)

EDEN PRAIRIE, MN 55344
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.00001 par value                  94964   I   Held by "Davis & Associates 401K PSP"   (2)
Common Stock, $0.00001 par value                  57482   I   Held by "Davis & Associates Inc."   (2)
Common stock, $0.00001 par value                  2666139   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants   $5.00                      (1) 12/27/2012   Common stock, $0.00001 par value   5800     5800   D    
Warrants   $5.00                      (1) 12/27/2012   Common stock, $0.00001 par value   6050     6050   I   Held by "Davis & Associates Inc. 401K PSP"   (2)
Warrants   $5.00                      (1) 12/27/2012   Common stock, $0.00001 par value   700     700   I   Held by "Davis & Associates Inc."   (2)
Warrants   $1.50                      (1) 4/3/2013   Common stock, $0.00001 par value   25000     25000   D    
Warrants   $.50                      (1) 12/31/2012   Common stock, $0.00001 par value   30000     30000   D    
Warrants   $.70                      (1) 12/31/2012   Common stock, $0.00001 par value   30000     30000   D    
Warrants   $.70                      (1) 12/31/2012   Common stock, $0.00001 par value   10000     10000   I   Held by "Davis & Associates Inc. 401K PSP"   (2)
Warrants   $.70                      (1) 12/31/2012   Common stock, $0.00001 par value   5000     5000   I   Held by "Davis & Associates Inc."   (2)
Warrants   $1.00                      (1) 12/31/2012   Common stock, $0.00001 par value   30000     30000   D    
Warrants   $1.50                      (1) 9/25/2013   Common stock, $0.00001 par value   100000     100000   D    
Warrants   $2.00                      (1) 10/31/2013   Common Stock, $0.00001 par value   16667     16667   D    
Warrants   $1.30                      (1) 1/7/2014   Common Stock, $0.00001 par value   195000     195000   D    
Options   $2.41                      (1) 3/1/2017   Common stock, $0.00001 par value   10374     10374   D    
Warrant   $1.30                      (1) 7/12/2013   Common stock, $0.00001 par value   100000     100000   D    
Warrant   $1.30                      (1) 7/12/2013   Common stock, $0.00001 par value   20000     20000   I   Held by "Davis & Associates Inc. 401(k) PSP"   (2)
Warrant   $1.30                      (1) 7/12/2013   Common stock, $0.00001 par value   20000     20000   I   Held by "Davis & Associates Inc."   (2)
Warrants   $1.30                      (1) 8/2/2013   Common stock, $0.0001 par value   286923     286923   D    
Warrants   $1.30                      (1) 1/7/2014   Common stock, $0.00001 par value   54964     54964   I   Held by "Davis & Associates Inc. 401K PSP"   (2)
Warrants   $1.30                      (1) 8/2/2013   Common stock, $0.0001 par value   20000     20000   I   Held by Davis & Associates, Inc. 401(k) PSP   (2)
Warrants   $1.30                      (1) 1/7/2014   Common stock, $0.00001 par value   17482     17482   I   Held by "Davis & Associates Inc."   (2)
Warrants   $1.30                      (1) 8/2/2013   Common stock, $0.0001 par value   20000     20000   I   Held by Davis & Associates, Inc.   (2)
Options   $1.72                      (1) 8/10/2017   Common stock, $0.00001 par value   14535     14535   D    
Warrants   $1.30                      (1) 1/7/2014   Common stock, $0.00001 par value   50000     50000   D    
Stock options   $0.87                      (1) 8/9/2018   Common stock, $0.00001 par value   28736     28736   D    
Convertible Note   (3) $1.30                      (1) 9/20/2013   Common stock, $0.00001 par value     (5)   $150000   D    
Convertible Note   $1.10                      (1) 8/28/2012   (5) Common Stock, $0.00001 par value     (5)   $11758   D    
Warrant   $1.30                      (1) 1/7/2014   Common stock, $0.00001 par value   62923     62923   D    
Convertible Note   $1.30                      (1) (6) 9/20/2013   Common stock, $0.00001 par value   76923     250000   D    
Stock Options   $0.60   8/9/2012     A      25000         (4) 8/9/2019   Common stock, $0.00001 par value   25000   $0   25000   D    

Explanation of Responses:
( 1)  Currently exercisable
( 2)  Reporting person is the Sole owner of Davis & Associates Inc. and has sole voting power.
( 3)  On October 31, 2011, the reporting person purchased a $100,000, 10% convertible secured subordinated promissory note from the issuer in a private placement. The promissory note and any accrued interest thereon is convertible at any time at the option of the reporting person into common stock at $1.30 per share. The promissory note matures on September 20, 2013, and may be called any time after the price of the issuer's common stock exceeds $4.00 per share for 10 consecutive days. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The issuer's Board of Directors specifically approved the reporting person's participation in the private placement as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).
( 4)  Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors. The seven-year options vest ratably over 12 months.
( 5)  The principal amount and interest thereon accruing at a rate of 10% per year are convertible into common shares at $1.10 per share at any time through the August 28, 2012 maturity date. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rules 16b-3(d).
( 6)  On March 30, 2012, the reporting person purchased a $100,000, 10% convertible secured subordinated promissory note from the issuer in a private placement. The promissory note and any accrued interest thereon is convertible at any time at the option of the reporting person into common stock at $1.30 per share. The promissory note matures on March 31, 2014, and may be called any time after the price of the issuer's common stock exceeds $4.00 per share for 10 consecutive days. The issuer's Board of Directors specifically approved the reporting person's participation in the private placement as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DAVIS JAMES L
6446 FLYING CLOUD DR
EDEN PRAIRIE, MN 55344
X X


Signatures
Richard B. Thon by power of attorney 8/10/2012
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more ProUroCare Medical (CE) Charts.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more ProUroCare Medical (CE) Charts.